<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5507">
  <stage>Registered</stage>
  <submitdate>27/06/2008</submitdate>
  <approvaldate>27/06/2008</approvaldate>
  <nctid>NCT00708630</nctid>
  <trial_identification>
    <studytitle>The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination</studytitle>
    <scientifictitle>The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>KPKF001</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Vaccination</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Behaviour - Extended information on side effects

Experimental: 1 - Provision of extended symptom side effects information

No Intervention: 2 - Standard information on side effects


Behaviour: Extended information on side effects
More detailed information on possible side effects of vaccine

</interventions>
    <comparator />
    <control />
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>symptom report scale</outcome>
      <timepoint>20 minutes and 1 week post vaccination</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>patient satisfaction scale</outcome>
      <timepoint>20 minutes and 1 week post vaccination</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Receiving yellow fever vaccination

          -  English speaker

          -  Aged over 18</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  No phone for follow-up</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Health Services Research</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>100</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University of Auckland, New Zealand</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to investigate the effect of providing additional information about possible
      mild side effects of the yellow fever vaccination on the reporting of physical symptoms.
      Additionally, the project aims to investigate the relationship between individual
      characteristics (trait anxiety and perceived sensitivity to medication) and the reporting of
      physical symptoms, as well as possible interactions between the level of information provided
      and individual characteristics. We hypothesize that more information about mild symptoms
      provided to participants will increase the number of reported symptoms after vaccination.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00708630</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Keith J Petrie, PhD</name>
      <address>University of Auckland, New Zealand</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>